Skip to main content

Advertisement

Table 5 Overall survival by treatment status and histologic categories

From: Treatment patterns and survival among older adults in the United States with advanced soft-tissue sarcomas

Overall Survival from initial diagnosis of advanced STS
Total Died Censored Median length of survival (in months) 95% CI
All advanced STS patients 4274 3565 709 8.9 8.3 9.7
Treatment status
 Received cancer-directed treatment 2656 2185 471 13.6 12.9 14.6
 Received supportive care only 1618 1380 238 2.8 2.6 3.4
Histologic categories
 Fibroblastic/myofibroblastic sarcomas 227 160 67 21.4 15.6 26.8
 Leiomyosarcomas 922 781 141 12.9 10.9 14.6
 Liposarcomas 554 395 159 21.1 17.4 27.1
 Nerve sheath sarcomas 106 88 18 6.2 3.6 9.3
 Rhabdomyosarcomas 98 3.0 1.8 5.7
 Synovial sarcomas 49 8.6 5.3 13.8
 Undifferentiated pleomorphic sarcomas 652 539 113 9.6 8.2 11.4
 Vascular sarcomas 357 327 30 6.0 4.8 7.3
 Others/NOS 1309 1139 170 5.4 4.8 6.1
  1. CI confidence interval, NOS not otherwise specified, STS soft-tissue sarcoma